| Oct 9 |
Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date
|
| Oct 8 |
Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings
|
| Oct 3 |
Investors in Simulations Plus (NASDAQ:SLP) have unfortunately lost 26% over the last year
|
| Oct 3 |
OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last?
|
| Oct 1 |
Improve Demand Lifted Simulations Plus (SLP)
|
| Sep 12 |
3 US Growth Companies Insiders Are Betting On
|
| Sep 12 |
Is There An Opportunity With Simulations Plus, Inc.'s (NASDAQ:SLP) 41% Undervaluation?
|
| Aug 28 |
Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
|
| Aug 23 |
Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions
|
| Aug 22 |
Simulations Plus: Declining Margins Are A Problem
|
